1. Effect of gemfibrozil and rifampicin on the pharmacokinetics of selexipag and its active metabolite in healthy subjects. (16th August 2017) Authors: Bruderer, Shirin; Petersen‐Sylla, Marc; Boehler, Margaux; Remeňová, Tatiana; Halabi, Atef; Dingemanse, Jasper Journal: British journal of clinical pharmacology Issue: Volume 83:Number 12(2017) Page Start: 2778 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effect of hepatic impairment on the pharmacokinetics and pharmacodynamics of a single dose of rivaroxaban, an oral, direct Factor Xa inhibitor. (20th June 2013) Authors: Kubitza, Dagmar; Roth, Angelika; Becka, Michael; Alatrach, Abir; Halabi, Atef; Hinrichsen, Holger; Mueck, Wolfgang Journal: British journal of clinical pharmacology Issue: Volume 76:Number 1(2013:Jul.) Page Start: 89 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effect of hepatic impairment on the pharmacokinetics of vilaprisan: An open‐label, single‐dose, parallel‐group study. Issue 9 (10th July 2019) Authors: Chattopadhyay, Niladri; Riecke, Kai; Ligges, Sandra; Zimmermann, Torsten; Halabi, Atef; Schultze‐Mosgau, Marcus‐Hillert Journal: British journal of clinical pharmacology Issue: Volume 85:Issue 9(2019) Page Start: 2011 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effect of lopinavir/ritonavir on the pharmacokinetics of selexipag an oral prostacyclin receptor agonist and its active metabolite in healthy subjects. (12th June 2015) Authors: Kaufmann, Priska; Niglis, Séverine; Bruderer, Shirin; Segrestaa, Jérôme; Äänismaa, Päivi; Halabi, Atef; Dingemanse, Jasper Journal: British journal of clinical pharmacology Issue: Volume 80:Number 4(2015:Oct.) Page Start: 670 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Influence of hepatic impairment on the pharmacokinetics and pharmacodynamics of the P2Y12 receptor antagonist selatogrel. Issue 8 (18th May 2022) Authors: Schilling, Uta; Hsin, Chih‐Hsuan; Delahaye, Stephane; Krause, Andreas; Wuelfrath, Hauke; Halabi, Atef; Dingemanse, Jasper Journal: Clinical and translational science Issue: Volume 15:Issue 8(2022) Page Start: 1906 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Pharmacokinetics and pharmacodynamics of ponesimod, a selective S1P1 receptor modulator, in the first‐in‐human study. (December 2013) Authors: Brossard, Patrick; Derendorf, Hartmut; Xu, Jian; Maatouk, Haidar; Halabi, Atef; Dingemanse, Jasper Journal: British journal of clinical pharmacology Issue: Volume 76:Number 6(2013:Dec.) Page Start: 888 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Pharmacokinetics and safety of letermovir, a novel anti‐human cytomegalovirus drug, in patients with renal impairment. (5th May 2017) Authors: Kropeit, Dirk; Scheuenpflug, Jürgen; Erb‐Zohar, Katharina; Halabi, Atef; Stobernack, Hans‐Peter; Hulskotte, Ellen G. J.; van Schanke, Arne; Zimmermann, Holger; Rübsamen‐Schaeff, Helga Journal: British journal of clinical pharmacology Issue: Volume 83:Number 9(2017) Page Start: 1944 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Pharmacokinetics and safety of teneligliptin in subjects with hepatic impairment. Issue 4 (17th February 2014) Authors: Halabi, Atef; Maatouk, Haidar; Siegler, Karl Ernst; Faisst, Nadja; Hinrichsen, Holger Journal: Clinical pharmacology in drug development Issue: Volume 3:Issue 4(2014:Jul./Aug.) Page Start: 290 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Pharmacokinetics of bound and unbound telaprevir in cirrhotic patients with moderate and severe hepatic impairment. (7th July 2015) Authors: Ouwerkerk‐Mahadevan, Sivi; Halabi, Atef; Cieslarová, Blanka; Aerts, Indra; Witek, James; Van Solingen‐Ristea, Rodica; Luo, Donghan Journal: Journal of clinical pharmacology Issue: Volume 55:Number 10(2015:Oct.) Page Start: 1147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Pharmacokinetics of serelaxin in patients with hepatic impairment: a single‐dose, open‐label, parallel group study. (June 2015) Authors: Kobalava, Zhanna; Villevalde, Svetlana; Kotovskaya, Yulia; Hinrichsen, Holger; Petersen‐Sylla, Marc; Zaehringer, Andreas; Pang, Yinuo; Rajman, Iris; Canadi, Jasna; Dahlke, Marion; Lloyd, Peter; Halabi, Atef Journal: British journal of clinical pharmacology Issue: Volume 79:Number 6(2015:Jun.) Page Start: 937 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗